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CASE PrESEntAtion
A 48-year-old woman presented with floaters, 
photopsia, blurred vision and ocular pain in both 
eyes of a few days’ duration prior to referral. She 
had a history of diabetes mellitus for 10 years and 
was being treated with glibenclamide and metformin.
On examination, visual acuity was 20/160 and 
20/50 in the right and left eyes, respectively with 
no significant refractive error. Both pupils were 
normally reactive and no afferent pupillary defect 
was present. Slit lamp examination disclosed 1+ 
cell in the anterior chamber, pigmentation of the 
anterior lens capsule, 2+ nucleus sclerosis and 1+ to 
2+ vitreous cells in both eyes. Intraocular pressure 
was 16 mmHg in both eyes. Fundus examination 
revealed multiple well-circumscribed creamy-yellow 
subretinal lesions, mostly distributed in equatorial 
and peripapillary regions, together with dot and 
blot retinal hemorrhages, macular edema and florid 
neovascularization of the optic discs (Fig. 1).
Fluorescein angiography (FA) demonstrated 
early hypo- and late hyperfluorescence of the 
lesions (Fig. 2). Apart from diffuse optic disc 
leakage, macular leakage was also notable. On 
indocyanine green (ICG) angiography, the lesions 
remained hypofluorescent through all phases of the 
angiogram (Fig. 3).
Laboratory investigations including VDRL, 
serum angiotensin-converting enzyme level and 
skin tuberculin test (STT), were within normal 
limits and HLA-A29 was negative. Chest X-ray 
was also unremarkable.
What are your differential diagnoses?
Figure 1. Fundus appearance at presentation.
Figure 2. Fluorescein angiography at presentation (early 
and late frames).
Figure 3. Indocyanine green angiography at presentation 
(early and late frames).Challenging Case; Multifocal Choroiditis
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The presence of multiple creamy-white fundus 
lesions together with characteristic ICG 
angiographic features are in keeping with a 
diagnosis of “choroiditis”, which can broadly 
be categorized into choriocapillaropathies and 
stromal choroiditis. Multiple evanescent white 
dot syndrome (MEWDS), a primary inflammatory 
choriocapillaritis, has features in common with 
this case. It usually causes visual loss, photopsia 
and scotomata, and ICG angiography reveals 
numerous hypofluorescent spots mostly in the 
peripapillary region. However, MEWDS is usually 
unilateral and self-limited, which was not the 
case in this patient. Other primary inflammatory 
choriocapillaropathies such as acute posterior 
multifocal placoid pigment epitheliopathy 
(APMPPE) and serpiginous choroiditis, although 
bilateral in most cases, cause geographic or 
helicoidal subretinal lesions which are distinct 
from the well-circumscribed spot-like lesions 
seen in this patient. Vogt-Koyanagi-Harada 
(VKH) syndrome, a primary stromal choroiditis, 
has numerous hypofluorescent dark dots 
(HDD) on ICG angiography which resembles 
this case. However, the absence of neurologic/
auditory symptoms, serous retinal detachment, 
and stromal choroidal vasculitis (intermediate 
fuzzy stromal vessels and late diffuse choroidal 
hyperfluorescence on ICG) are against this 
diagnosis. Birdshot chorioretinopathy, another 
primary stromal choroiditis, may present similar 
to this case, but a negative HLA-A29 and lack of 
prominent retinal vasculitis make it less likely. 
The diffuse and rather regular distribution of 
the choroidal lesions (as depicted by HDD 
on ICG angiograms) and lack of laboratory 
evidence reduce the possibility of ocular 
tuberculosis (TB) and sarcoidosis in this case. 
This patient demonstrates combined features 
of choriocapillaropathies (choriocapillaris non-
perfusion) and stromal choroiditis (HDD on 
ICG angiography) and may best be labelled as 
“multifocal choroiditis”.
touka Banaee, MD
The patient described herein is an interesting 
case of bilateral multifocal choroidal 
inflammation/infiltration combined with 
diabetic retinopathy. When uveitis especially, 
choroiditis occurs in a diabetic patient, there are 
several diagnostic and therapeutic challenges 
that must be addressed. One challenge is ruling 
out opportunistic infections of the choroid. The 
list of differential diagnoses for this patient 
may include the following.
1- Idiopathic inflammations of the choroid:
•	 Birdshot chorioretinopathy
•	 Multifocal choroiditis and panuveitis 
syndrome
2- Granulomatous inflammations and infections:
•	 Sarcoidosis
•	 Tuberculosis and atypical mycobacterial 
infections
•	 Syphilis
3- Malignancies:
•	 Intraocular lymphoma
•	 Metastatic infiltration of the choroid
4- Fungal infections of the choroid:
•	 Cryptococcus neoformans
•	 Pneumocystis carinii
•	 Coccidioides immitis
•	 Sporothrix schenckii
Sarcoidosis, miliary tuberculosis and 
syphilis may lead to a picture similar to this 
case. However, normal systemic examination, 
negative laboratory tests and normal chest X-ray 
rule out all of these diagnoses. I myself would 
recheck the skin test with a double strength 
test when the clinical picture is compatible 
with tuberculous uveitis. This has not been 
performed for this case, but the clinical course 
(described below) proves the condition not to be 
tuberculosis because it would have aggravated 
under corticosteroid and immunomodulatory 
treatment.
In my opinion, intraocular lymphoma and 
choroidal metastasis are also unlikely due to 
the absence of neurological symptoms and the 
presence of significant vitreous inflammation. 
Furthermore, the clinical course makes such 
possibilities very unlikely; the patient did not 
develop systemic symptoms nor did the ocular 
condition aggravate during follow-up.Challenging Case; Multifocal Choroiditis
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Atypical fungal infections such as those 
caused by Cryptococcus neoformans, Pneumocystis 
carinii, Coccidioides immitis, and Sporothrix 
schenckii may produce such a clinical picture, 
usually in the context of systemic involvement 
and immunosuppression. The normal systemic 
condition, normal chest X-ray, and the 
course of the disease make these diagnoses   
remote.
The most likely remaining diagnoses 
are the first category in the differential 
diagnosis listed above, namely idiopathic 
choroidal inflammations. Although a negative 
HLA-A29 makes the diagnosis of birdshot 
chorioretinopathy unlikely, the clinical picture 
of cream-colored, radially-oriented choroidal 
lesions with nearly same sizes in a middle-
aged woman is compatible with a diagnosis 
of birdshot chorioretinopathy rather than 
multifocal choroiditis and panuveitis syndrome. 
Although HLA-A29 may be negative in 4 to 
10% of cases with birdshot chorioretinopathy, 
certain findings are in favor of multifocal 
choroiditis and panuveitis syndrome. The 
hypofluorescent spots on ICG angiography 
in this case are smaller, of unequal sizes and 
more randomly distributed than what is seen 
in birdshot chorioretinopathy. Another clue is 
the development of late subretinal fibrosis as 
observed on fundus photographs and optical 
coherence tomography (OCT) images (depicted 
below). Multifocal choroiditis and panuveitis 
syndrome, and the idiopathic subretinal fibrosis 
syndrome are considered entities along one 
spectrum and treatment does not differ much 
between them.
With a diagnosis of multifocal choroiditis and 
panuveitis, oral cyclosporine A 3 mg/kg per day 
and prednisolone 25 mg per day, along with topical 
betamethasone QID and tropicamide TDS were 
initiated in both eyes. Six weeks after starting 
treatment, the patient reported an improvement 
and visual acuity reached 20/120 in the right eye 
and 20/60 in the left one. Vitreous reaction and 
choroiditis diminished but neovascularization of the 
discs remained unchanged. At this time, prednisolone 
was gradually tapered to 12.5 mg and then to 
7.5 mg per day and cyclosporine was continued 
at 200 mg daily. Two months later, the patient 
returned with deterioration of vision in both eyes 
to 20/200. Despite control of the inflammation in 
both eyes, disc neovascularization persisted (Fig. 4), 
therefore full scatter panretinal photocoagulation 
(PRP) was performed.
Do you agree with performing PRP at this stage?
Alireza Hedayatfar, MD
The main area of inflammation in multifocal 
choroiditis is the choroid. Development of 
retinal lesions and vitreous infiltration is a 
secondary process, therefore a quiet anterior 
chamber and vitreous does not necessarily 
indicate well-controlled inflammation. ICG 
would be a more precise and reliable measure 
to evaluate disease activity. In fact, visual 
deterioration and progression of fundus lesions 
(apparent by comparison of the two successive 
color fundus photographs) are indicators of 
insufficient control of inflammation. Nodularity 
and irregular thickening of the retinal pigment 
epithelium (RPE), as revealed on OCT images, 
further support the presence of an active state. 
In a burnt out state, the corresponding scars 
would have caused atrophic changes.
Persistent disc neovascularization may 
be attributed to both retinal ischemia due 
to diabetic retinopathy and/or persistent 
ocular inflammation. The etiopathology of 
neovascularization in inflammatory diseases 
(secondary to inflammatory cytokines) 
is different from diabetic retinopathy 
(subsequent to retinal ischemia); therefore, 
further suppression of inflammation would 
have been indicated before attempting laser 
Figure 4. Fundus appearance 3.5 months after starting 
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photocoagulation which in turn, may exacerbate 
macular leakage. Personally, I think PRP would 
have been indicated only if an ICG angiogram 
had already revealed an inactive state.
touka Banaee, MD
I completely agree with starting a high dose 
of steroids with low dose cyclosporine, and 
tapering steroids a few weeks later. In a diabetic 
patient, one must bear in mind the possibility 
of enhanced drug complications and monitor 
the patient closely. Fortunately, the authors 
have handled the case smoothly and without 
complications.
Neovascularization of the optic disc can 
be due to diabetes or uveitis. There are not 
many dot and blot hemorrhages or other 
signs of diabetic retinopathy in the fundus 
photographs, and the neovascularization may 
be assumed to be secondary to uveitis. If disc 
neovascularization is due to uveitis, then it 
may regress upon control of the inflammation. 
If it does not regress after controlling disease 
activity, PRP is indicated as had been done in 
this patient.
During the next 4 months, the patient’s vision 
deteriorated progressively and visual acuity 
dropped to 20/400 in both eyes despite control of 
the inflammation. At this time mild vitreous and 
pre-retinal hemorrhages were detected in her left eye. 
OCT showed increased central macular thickness 
in both eyes (Fig. 5). At this stage, an intravitreal 
injection of bevacizumab was performed in the left 
eye; 18 months later, visual acuity decreased to 
5/200 in the right eye and 20/400 in the left eye. On 
fundus examination pre-retinal and fresh vitreous 
hemorrhages were visible in her left eye (Fig. 6).
Vitreoretinal surgery was performed on the 
left eye. However, due to a cataract and permanent 
macular damage, visual acuity did not improve 
significantly. The patient eventually underwent 
phacoemulsification with posterior chamber 
intraocular lens implantation in both eyes. At final 
examination, visual acuity improved to 20/200 with 
complete control of the inflammation while she 
was on medical therapy with cyclosporine 75 mg 
per day and prednisolone 7.5 mg every other day.
What would you suggest for further management?
Alireza Hedayatfar, MD
I would look for signs of subclinical disease 
activity; combined FA/ICG angiography 
would be a good option at this stage. If the 
disease is not fully controlled and HDDs are 
still present on ICG angiography, one could 
increase the dose of cyclosporine A, switch 
to another immunosuppressive agent (e.g. 
azathioprine) or add one to the current regimen. 
If there is no disease activity, the patient can 
be kept on the current medications. Lesions 
Figure 5. OCT and fundus photography 8 months after 
starting treatment.
Figure 6. OCT and fundus photography 26 months after 
starting treatment.Challenging Case; Multifocal Choroiditis
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that remain hypofluorescent throughout the 
intermediate and late phases of angiograms 
may correspond to areas of choroidal scarring 
and should not be interpreted as indicators of 
disease activity. Evidence for early choroidal 
neovascular membrane (CNVM) should also 
be sought for. Meanwhile, residual optic disc 
neovascularization could be managed by further 
laser photocoagulation and/or intravitreal 
anti-vascular endothelial growth factor (VEGF) 
injections, once the inflammation is quiescent. 
Anti-VEGF agents offer the advantage of 
simultaneous treatment of an associated CNVM.
touka Banaee, MD
The continued decrease of vision in this case 
during follow up has not been adequately 
addressed. This may be due to macular 
ischemia secondary to diabetic retinopathy, 
which we do not have a fluorescein angiogram 
to confirm. No thickness maps of the macula 
are presented, and OCT images show some 
degree of macular edema which seems unlikely 
to lead to a significant decrease in vision. 
There is subretinal tissue just under the fovea 
in both eyes, which may be due to fibrosis or 
formation of CNVM. There are no accompanying 
fluorescein angiograms to reveal the cause but 
this sub-foveal tissue can be considered as the 
main cause of visual loss. Some epiretinal tissue 
with vitreomacular traction is also present in 
both eyes.
It has been stated that disease activity 
was controlled, an impression which seems 
to be based on clinical findings. It would be 
prudent to perform FA and ICG angiography 
to exclude the presence of subclinical choroidal 
inflammation. Furthermore, these studies 
would help delineate the cause of visual loss; 
whether there had been progression of macular 
ischemia, or formation of CNVM.
The left eye received an injection of 
bevacizumab. There are no notes to the 
indication for injection. If it had been done to 
treat macular edema, it is not clear what the 
result has been and why it was not repeated. 
Such injections are sometimes performed to 
induce regression of active neovascularization 
as a temporary measure before PRP, but this 
seems unlikely since PRP was performed several 
months later.
The authors have not stated the indication for 
vitreoretinal surgery. The vitreous hemorrhage 
had been mild and the uveitis had been under 
control. I suppose that, it surgery was done 
to relieve vitreomacular traction and macular 
edema. Performing a fluorescein angiography 
before surgery would have helped prognosticate 
the visual results by assessing the state of the 
perifoveal capillary net, and presence or absence 
of subretinal neovascularization and leakage.
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